Medical Marijuana: DEA Judge Says Let Professor Grow Marijuana for Research Purposes

A Drug Enforcement Administration (DEA) administrative law judge ruled Monday that a professor at the University of Massachusetts at Amherst should be allowed to grow marijuana for research purposes. The ruling is non-binding, and the decision resides ultimately in the hands of DEA head Karen Tandy, but the decision by Judge Mary Ellen Bittner paves the way for Professor Lyle Craker, a horticulturist specializing in medicinal plants, to possibly become the second authorized grower of marijuana for research purposes in the United States.
Lyle Craker (courtesy
Currently, only a long-standing government-approved program at the University of Mississippi can legally grow marijuana for research purposes. But Craker and others have long argued that marijuana from the Mississippi garden is neither readily available nor of sufficient quality and strength to be useful for researchers.

Craker first applied to the DEA for permission to grow marijuana for research purposes in 2001 and won the support of home state senators Edward Kennedy and John Kerry for the project. But for years, the DEA refused to act on the request, and in 2004, Craker and the Multidisciplinary Association for Psychedelic Studies (MAPS) sued the agency, charging it with unreasonable delays in dealing with his application.

After hearings last year, the agency responded by denying his application, saying that there was no shortage of marijuana for research purposes, and Craker and his private backers were free to submit bids to compete for the marijuana-growing contract. But Craker and MAPS vehemently disagreed and sought a ruling by a DEA administrative law judge.

In her Monday ruling, Judge Bittner found that Craker's bid to grow marijuana "would be in the public interest." Her opinion noted that: "There would be minimal risk of diversion of marijuana. There is currently an inadequate supply of marijuana available for research purposes... [and] competition in the provision of marijuana for such purposes is inadequate."

While the decision is not definitive -- the DEA has 20 days to respond, and it may ignore the judge's findings -- Professor Craker and MAPS greeted the decision with guarded optimism. "This ruling is a victory for science, medicine and the public good," said Craker in an MAPS press release. "I hope the DEA abides by the decision and grants me the opportunity to do my job unimpeded by drug war politics."

"For decades, politicians have said that marijuana has no proven medical value while scientists have been denied the ability to prove otherwise," said Rick Doblin, PhD, president and founder of MAPS.

The American Civil Liberties Union Drug Law Reform Project, which helped argue the case, also pronounced itself pleased with the ruling. "For too long the DEA has inappropriately inserted politics into a regulatory process that should be left to the FDA and medical science," said Allen Hopper, an attorney with the project, in a press release. "We are pleased that the judge has recommended an end to the federal government's blockade of medical marijuana research."

The DEA has refused to comment on the ruling so far, but, as noted above it is non-binding. Optimism over the ruling is tempered by the memory of DEA's administrative law Judge Francis Young's 1988 finding that marijuana is among the most benign therapeutic substances known to man. That ruling came in a bid to reschedule marijuana as a prescription medicine, but was ignored by the agency.

"I hope that Administrator Tandy abides by the decision and grants me the opportunity to do my job unimpeded by drug war politics," Craker said.

There is strong support for Craker and MAPS's bid to grow their own marijuana to do DEA- and FDA-approved research on the medicinal uses of marijuana. Prior to this week's ruling, organizations that had already written to DEA in favor of Prof. Craker's application included the Multiple Sclerosis Foundation, the Lymphoma Foundation of America, the National Association for Public Health Policy, the United Methodist Church, Americans for Tax Reform, the American Medical Students Association, several state nurses' associations, the Massachusetts Dept. of Public Health, Massachusetts Senators Kerry and Kennedy, 38 members of the US House of Representatives, and the California and Texas State Medical Associations, the two largest US state medical associations.

Now, it is time to keep the pressure on.

Permission to Reprint: This article is licensed under a modified Creative Commons Attribution license.
Looking for the easiest way to join the anti-drug war movement? You've found it!


can u grow pot ??????

Hopefully, the N.R.A. will

Hopefully, the N.R.A. will finally grow some balls and speak up on stuff like this!
What gives the D.E.A. the right to ignore a JUDGE'S orders??!!!
This arrogance is not tobe taken lightly, even if we don't agree with the verdict a judge hands down, IT STILL MUST BE RESPECTED!!!
A government administration IGNORING a judge's orders should ALARM THE HELL OUT OF EVERY CITIZEN OF THIS COUNTRY!!!!

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd> <i> <blockquote> <p> <address> <pre> <h1> <h2> <h3> <h4> <h5> <h6> <br> <b>

More information about formatting options

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, Vaping, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Pill Testing, Safer Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psilocybin / Magic Mushrooms, Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School